{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:26:09Z","timestamp":1769009169992,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.mycmed.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T09:15:25Z","timestamp":1502183725000},"page":"519-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles"],"prefix":"10.1016","volume":"27","author":[{"given":"T.C.","family":"Moraes Moreira Carraro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Altmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Maissar Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mara Mainardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2017.07.004_bib0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1517\/17425240902802861","article-title":"The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis","volume":"6","author":"Thornton","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcrc.2010.08.005","article-title":"The value of amphotericin B in the treatment of invasive fungal infections","volume":"26","author":"Klepser","year":"2011","journal-title":"J Crit Care"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"30years of clinical experience","volume":"12","author":"Gallis","year":"2013","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/138920009788898019","article-title":"and its new derivatives\u00a0\u2013\u00a0Mode of action","volume":"10","author":"Baginski","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10611869708995847","article-title":"Release of amphotericin B from delivery systems and its action against fungal and mammalian cells","volume":"4","author":"Legrand","year":"1997","journal-title":"J Drug Target"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0960-894X(96)00059-5","article-title":"Probing the mechanism of action of amphotericin B","volume":"6","author":"James","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(02)00071-3","article-title":"The effects of amphotericin B on pure and ergosterol- or cholesterol-containing dipalmitoylphosphatidylcholine bilayers as viewed by 2H NMR","volume":"119","author":"Paquet","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0235","doi-asserted-by":"crossref","first-page":"16743","DOI":"10.1021\/jp061916g","article-title":"Modulation of amphotericin B membrane interaction by cholesterol and ergosterol\u00a0\u2013\u00a0A molecular dynamics study","volume":"110","author":"Czub","year":"2006","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: a review","volume":"12","author":"Fanos","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0245","first-page":"119","article-title":"Nephrotoxicity of Amphotericin B","volume":"23","author":"Deray","year":"2002","journal-title":"Nephrologie"},{"issue":"Suppl 1","key":"10.1016\/j.mycmed.2017.07.004_bib0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of the lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2008.01979.x","article-title":"lipid preparations: what are the differences?","volume":"14","author":"Adler-moore","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0260","first-page":"154","article-title":"Commercially available lipid formulations of amphotericin B: Are they bioequivalent and therapeutically equivalent?","volume":"83","author":"Cifani","year":"2012","journal-title":"Acta Biomed"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","article-title":"Biodegradable nanoparticles for drug delivery and targeting","volume":"6","author":"Hans","year":"2002","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0285","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.colsurfb.2012.06.024","article-title":"Pharmacokinetics of curcumin-loaded PLGA and PLGA\u2013PEG blend nanoparticles after oral administration in rats","volume":"101","author":"Khalil","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0300","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jps.21406","article-title":"Zidovudine-loaded PLA and PLA-PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells","volume":"98","author":"Mainardes","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0305","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s10856-009-3746-9","article-title":"In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content","volume":"20","author":"Sheng","year":"2009","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/10837450.2014.979942","article-title":"Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design","volume":"21","author":"Carraro","year":"2016","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0315","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1166\/jnn.2015.9177","article-title":"Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity","volume":"15","author":"Casa","year":"2015","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0320","series-title":"Performance standards for antimicrobial susceptibility testing. 17th Informational Suppl Wayne","author":"Wayne","year":"2007"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0325","doi-asserted-by":"crossref","first-page":"e25744","DOI":"10.1371\/journal.pone.0025744","article-title":"Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome\u00ae or FungizoneTM","volume":"6","author":"Italia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejmech.2015.03.022","article-title":"Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles","volume":"95","author":"Souza","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0335","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jac\/dkn539","article-title":"Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis","volume":"63","author":"Amaral","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0340","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","article-title":"PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome","volume":"161","author":"Van De Ven","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0345","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/mp500527x","article-title":"Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles","volume":"12","author":"Serrano","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0350","first-page":"5150","article-title":"Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles","volume":"8","author":"Tang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0355","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2016.1228715","article-title":"Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats","volume":"24","author":"Radwan","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0360","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/1061186X.2013.789033","article-title":"Nanocarriers for oral drug delivery","volume":"21","author":"Zhang","year":"2013","journal-title":"J Drug Target"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0365","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2011.02.039","article-title":"Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density","volume":"411","author":"Essa","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0370","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.20094","article-title":"Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA\/PLA nanoparticles","volume":"93","author":"Panyam","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0375","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2010.05.020","article-title":"Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles","volume":"395","author":"Mainardes","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0380","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/yea.2997","article-title":"Cryptococcus neoformans: historical curiosity to modern pathogen","volume":"31","author":"Srikanta","year":"2014","journal-title":"Yeast"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0385","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/IAI.00358-12","article-title":"Macrophage autophagy in immunity to cryptococcus neoformans and candida albicans","volume":"80","author":"Nicola","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.mycmed.2017.07.004_bib0390","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/apc.2006.20.227","article-title":"Emergence of amphotericin B-resistant cryptococcus laurentii meningoencephalitis shortly after treatment for cryptococcus neoformans meningitis in a patient with AIDS","volume":"20","author":"Manfredi","year":"2006","journal-title":"AIDS Patient Care STDS"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317300872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523317300872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:18:04Z","timestamp":1761110284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523317300872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1156523317300872"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.07.004","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}